Histo-blood group glycans in the context of personalized medicine
- PMID: 26748235
- PMCID: PMC7117023
- DOI: 10.1016/j.bbagen.2015.12.026
Histo-blood group glycans in the context of personalized medicine
Abstract
Background: A subset of histo-blood group antigens including ABO and Lewis are oligosaccharide structures which may be conjugated to lipids or proteins. They are known to be important recognition motifs not only in the context of blood transfusions, but also in infection and cancer development.
Scope of review: Current knowledge on the molecular background and the implication of histo-blood group glycans in the prevention and therapy of infectious and non-communicable diseases, such as cancer and cardiovascular disease, is presented.
Major conclusions: Glycan-based histo-blood groups are associated with intestinal microbiota composition, the risk of various diseases as well as therapeutic success of, e.g., vaccination. Their potential as prebiotic or anti-microbial agents, as disease biomarkers and vaccine targets should be further investigated in future studies. For this, recent and future technological advancements will be of particular importance, especially with regard to the unambiguous structural characterization of the glycan portion in combination with information on the protein and lipid carriers of histo-blood group-active glycans in large cohorts.
General significance: Histo-blood group glycans have a unique linking position in the complex network of genes, oncodevelopmental biological processes, and disease mechanisms. Thus, they are highly promising targets for novel approaches in the field of personalized medicine. This article is part of a Special Issue entitled "Glycans in personalised medicine" Guest Editor: Professor Gordan Lauc.
Keywords: Blood group; Cancer; Glycan; Infection; Personalized medicine; Vaccine.
Copyright © 2016 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Mechanisms of disease: The human N-glycome.Biochim Biophys Acta. 2016 Aug;1860(8):1574-82. doi: 10.1016/j.bbagen.2015.10.016. Epub 2015 Oct 21. Biochim Biophys Acta. 2016. PMID: 26500099 Review.
-
Methods for the absolute quantification of N-glycan biomarkers.Biochim Biophys Acta. 2016 Aug;1860(8):1676-87. doi: 10.1016/j.bbagen.2016.03.003. Epub 2016 Mar 4. Biochim Biophys Acta. 2016. PMID: 26953846 Review.
-
Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives.Biochim Biophys Acta. 2016 Aug;1860(8):1623-39. doi: 10.1016/j.bbagen.2016.03.008. Epub 2016 Mar 8. Biochim Biophys Acta. 2016. PMID: 26968459 Review.
-
The promise of protein glycosylation for personalised medicine.Biochim Biophys Acta. 2016 Aug;1860(8):1583-95. doi: 10.1016/j.bbagen.2016.03.012. Epub 2016 Mar 15. Biochim Biophys Acta. 2016. PMID: 26987810 Review.
-
Histo-blood group carbohydrates as facilitators for infection by Helicobacter pylori.Infect Genet Evol. 2017 Sep;53:167-174. doi: 10.1016/j.meegid.2017.05.025. Epub 2017 May 31. Infect Genet Evol. 2017. PMID: 28577915 Review.
Cited by
-
The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human.Microorganisms. 2018 Aug 2;6(3):78. doi: 10.3390/microorganisms6030078. Microorganisms. 2018. PMID: 30072673 Free PMC article. Review.
-
Therapeutics through glycobiology: an approach for targeted elimination of malaria.Biologia (Bratisl). 2023 Jan 10:1-5. doi: 10.1007/s11756-023-01312-x. Online ahead of print. Biologia (Bratisl). 2023. PMID: 36643690 Free PMC article.
-
Glycosylation in health and disease.Nat Rev Nephrol. 2019 Jun;15(6):346-366. doi: 10.1038/s41581-019-0129-4. Nat Rev Nephrol. 2019. PMID: 30858582 Free PMC article. Review.
-
Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection.mBio. 2020 Mar 17;11(2):e00251-20. doi: 10.1128/mBio.00251-20. mBio. 2020. PMID: 32184242 Free PMC article.
-
Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.Cancers (Basel). 2022 Jan 27;14(3):645. doi: 10.3390/cancers14030645. Cancers (Basel). 2022. PMID: 35158915 Free PMC article. Review.
References
-
- Landsteiner K. Ueber Agglutinationserscheinungen normalen menschlichen Blutes. Wien. Klin. Wochenschr. 1901;14:1132–1134. - PubMed
-
- ISBT (International Society of Blood Transfusion) Red cell immunogenetics and blood group terminology. 2015. http://www.isbtweb.org/working-parties/red-cell-immunogenetics-and-blood... (2015) (accessed December 29, 2015)
-
- Ravn V., Dabelsteen E. Tissue distribution of histo-blood group antigens. APMIS. 2000;108:1–28. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials